GlassScriptPhysician profile
Matthew Alan Collins
NPI 1649392853
$40,847.61
in general payments reported to CMS, 2019-2025
38 companies · $10K in 2025
The $10K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $1,625 · 2021: $1,900 · 2022: $2,100 · 2023: $2,509 · 2024: $22K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $8,461 · Education: $8.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,968.36 |
| Food and Beverage | $8,460.93 |
| Education | $8.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $33,051.40 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $1,246.32 | 2019-2025 | |
| Boston Scientific Corporation | $814.89 | 2019-2025 | Axonics, Watchman Access System, Spaceoar System |
| Myriad Genetic Laboratories, INC. | $703.68 | 2020-2024 | Prolaris, Myrisk, Bracanalysis Cdx |
| Janssen Biotech, INC. | $625.63 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $565.57 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $506.38 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Axonics, INC. | $498.05 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $360.03 | 2019-2021 | |
| Abbvie INC. | $335.16 | 2021-2025 | Lupron Depot, Botox |
| Olympus America INC. | $212.83 | 2019-2025 | Itind System, Uretero-Reno Videoscope |
| Sumitomo Pharma America, INC. | $212.81 | 2023-2025 | Gemtesa, Orgovyx |
| Neotract INC. | $195.56 | 2019 | |
| Urogen Pharma, INC. | $158.27 | 2021-2025 | Jelmyto |
| Blue Earth Diagnostics | $156.82 | 2021-2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $154.18 | 2021-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $123.64 | 2019-2023 | Xiaflex |
| Urovant Sciences INC | $112.23 | 2021-2022 | |
| Emd Serono, INC. | $103.36 | 2025 | |
| Medtronic, INC. | $86.46 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $83.83 | 2023-2025 | Lynparza |
| Endo USA, INC. | $76.25 | 2024-2025 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $65.64 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Myovant Sciences INC. | $52.30 | 2021-2022 | |
| Smith+Nephew, INC. | $48.52 | 2020-2024 | Grafix Pl, Stravix |
| Ethicon US, LLC | $39.53 | 2023-2024 | Surgicel Nu-Knit, Stratafix |
| Novartis Pharmaceuticals Corporation | $38.45 | 2022-2025 | |
| Palette Life Sciences, INC. | $36.26 | 2022 | |
| Photocure INC | $28.17 | 2025 | Cysview |
| Allergan, INC. | $24.98 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $20.26 | 2023 | |
| Foundation Medicine, INC. | $19.99 | 2021 | |
| Coloplast Corp | $19.47 | 2019 | |
| Antares Pharma, INC. | $18.69 | 2022 | |
| Angiodynamics, INC. | $16.93 | 2024 | Nanoknife |
| Amgen INC. | $12.84 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.18 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.